Dr. Andrew B. Freeman

Claim this profile

Grant Medical Center

Studies Lung Cancer
Studies Malignant Solid Neoplasm
3 reported clinical trials
12 drugs studied

Area of expertise

1Lung Cancer
Andrew B. Freeman has run 2 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I
2Malignant Solid Neoplasm
Andrew B. Freeman has run 1 trial for Malignant Solid Neoplasm. Some of their research focus areas include:
Stage IV

Affiliated Hospitals

Image of trial facility.
Grant Medical Center
Image of trial facility.
OhioHealth Mansfield Hospital

Clinical Trials Andrew B. Freeman is currently running

Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Image of trial facility.

Stereotactic Radiosurgery vs Whole-Brain Radiotherapy

for Brain Metastasis from Lung Cancer

This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria

More about Andrew B. Freeman

Clinical Trial Related7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Andrew B. Freeman has experience with
  • Local Consolidation Therapy
  • Memantine Hydrochloride
  • Stereotactic Radiosurgery
  • Whole-Brain Radiotherapy
  • Carboplatin
  • Cisplatin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Andrew B. Freeman specialize in?
Is Andrew B. Freeman currently recruiting for clinical trials?
Are there any treatments that Andrew B. Freeman has studied deeply?
What is the best way to schedule an appointment with Andrew B. Freeman?
What is the office address of Andrew B. Freeman?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security